FGFR1 and cancer: Finally, in vitro studies of the interaction of the Ag(I) compounds with calf thymus (CT) DNA and serum albumins were employed to assess their potential to bind to bio-macromolecular targets and drug carriers, whereas molecular docking calculations on the overexpressed Fibroblast Growth Factor Receptor 1 (FGFR1) in the aforementioned cancer cells provided useful information for the likely implication of these properties in their bioactivity mechanisms.